targeting tigit to extend immunotherapy benefits to more cancer patients
Published 2 years ago • 899 plays • Length 55:16Download video MP4
Download video MP3
Similar videos
-
0:42
targeting tigit for cancer immunotherapy
-
39:06
expanding the benefits of immuno-oncology through novel rational targets and combinations
-
1:44:45
gaining an advantage over nsclc: how to achieve the greatest benefit with immunotherapy
-
1:03:39
deep insight into immuno-oncology: immunotherapy pathways, targets, and biomarkers
-
56:08
gaining confidence in predicting and assessing response to cancer immunotherapies
-
26:32
standard and alternative dosing regimens of immunotherapies and combinations in modern oncology
-
1:09:47
how to select the right immunotherapy for first-line treatment of advanced nsclc
-
47:55
advanced gastroesophageal cancers: maximizing the benefits of novel immunotherapy approaches
-
3:39
tumor-related immune checkpoints and the development of targeted cancer immunotherapies
-
25:23
targeting tumor mutations for personalized cancer immunotherapy
-
1:50:50
emerging biomarkers, new targets, and rational combinations in immuno-oncology
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
1:26:11
immunotherapy for the win against melanoma
-
3:23
immune checkpoints: targeting tigit
-
10:46
cancer immunotherapy workshop 2021 – introduction to imaging applications in immuno-oncology
-
3:48
overcoming resistance to immune checkpoint inhibitors in nsclc
-
33:17
maximizing the benefits and minimizing the risks of cancer immunotherapies
-
1:36:33
strengthening our grip on immuno-oncology in genitourinary cancers
-
3:45
tigit: harnessing the power of the immune system to help fight cancer